Page 138 - Orange Book Cumulative Supplement 10 October 2012

PRESCRIPTION AND OTC DRUG PRODUCT PATENT AND EXCLUSIVITY LIST - 32ND EDITION
A - 1
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content

PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
ABACAVIR SULFATE - ABACAVIR SULFATE
A091294 001 PC Dec 16, 2012
ACETYLCYSTEINE - ACETADOTE
N021539 001 8148356 May 21, 2026 DP
ACLIDINIUM BROMIDE - TUDORZA PRESSAIR
N202450 001 5840279 Jun 21, 2016 DP NCE Jul 23, 2017
6071498 Jun 21, 2016 DP
6681768 Aug 07, 2022 DP
6750226 Sep 05, 2020 DS DP U-1264
7078412 Jul 16, 2020 DS DP U-1263
8051851 Apr 22, 2027 DP

ADAPALENE; BENZOYL PEROXIDE - EPIDUO
N022320 001 8105618 Dec 23, 2022 U-1078
8129362 Jul 18, 2027 U-1078
8241649 Dec 23, 2022 DP
ALBUMIN HUMAN - OPTISON
N020899 001 M-120 Aug 17, 2015
ALBUTEROL SULFATE - PROAIR HFA
N021457 001 6446627 Dec 18, 2017 DP
8132712 Sep 07, 2028 DP
ALBUTEROL SULFATE - VENTOLIN HFA
N020983 001 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
ALCAFTADINE - LASTACAFT
N022134 001 >A> 5468743 Nov 21, 2013 DS DP
ALENDRONATE SODIUM - BINOSTO
N202344 001 7488496 Aug 11, 2023 DS DP
7964212 Mar 06, 2023 DS DP

ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA
N022217 001 8168616 Jul 05, 2025 DP
ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA
N022217 002 8168616 Jul 05, 2025 DP
ALVIMOPAN - ENTEREG
N021775 001 8112290 Jul 31, 2030 U-1225
AMBRISENTAN - LETAIRIS
N022081 001 RE42462 Jul 29, 2018 DS

AMBRISENTAN - LETAIRIS
N022081 002 RE42462 Jul 29, 2018 DS
AMINOLEVULINIC ACID HYDROCHLORIDE - LEVULAN
N020965 001 8216289 May 01, 2018 U-289
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT
N022314 001 8101599 May 16, 2023 DP